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Abstract
The serine and arginine-rich protein family (SR proteins) are highly conserved regulators of pre-mRNA splicing. SF2/ASF, a
prototype member of the SR protein family, is a multifunctional RNA binding protein with roles in pre-mRNA splicing, mRNA
export and mRNA translation. These observations suggest the intriguing hypothesis that SF2/ASF may couple splicing and
translation of specific mRNA targets in vivo. Unfortunately the paucity of endogenous mRNA targets for SF2/ASF has
hindered testing of this hypothesis. Here, we identify endogenous mRNAs directly cross-linked to SF2/ASF in different sub-
cellular compartments. Cross-Linking Immunoprecipitation (CLIP) captures the in situ specificity of protein-RNA interaction
and allows for the simultaneous identification of endogenous RNA targets as well as the locations of binding sites within the
RNA transcript. Using the CLIP method we identified 326 binding sites for SF2/ASF in RNA transcripts from 180 protein
coding genes. A purine-rich consensus motif was identified in binding sites located within exon sequences but not introns.
Furthermore, 72 binding sites were occupied by SF2/ASF in different sub-cellular fractions suggesting that these binding
sites may influence the splicing or translational control of endogenous mRNA targets. We demonstrate that ectopic
expression of SF2/ASF regulates the splicing and polysome association of transcripts derived from the SFRS1, PABC1, NETO2
and ENSA genes. Taken together the data presented here indicate that SF2/ASF has the capacity to co-regulate the nuclear
and cytoplasmic processing of specific mRNAs and provide further evidence that the nuclear history of an mRNA may
influence its cytoplasmic fate.
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Introduction
Eukaryotic messenger RNA (mRNA) must be processed prior to
programming protein synthesis. The minimal modifications for
most mRNAs include capping, pre-mRNA splicing and polyad-
enylation [1]. These reactions occur in the nucleus and must be
completed prior to nuclear export of the mRNA to the cytoplasm.
The cytoplasmic fate of mRNA is also subject to regulation at the
level of localization, stability and translational efficiency [2]. RNA
processing reactions have been extensively studied using biochem-
ical systems; however, these are functionally linked in living cells
providing increased efficiency and regulatory potential for gene
expression [3]. The molecular mechanisms responsible for the
coupling of post-transcriptional regulatory networks are poorly
understood. A subset of multi-functional mRNA binding proteins
operating at the interface of distinct RNA processing machineries
may contribute to coupling of post-transcriptional gene expression.
The Serine and Arginine-rich (SR) protein family consists of eight
phylogenetically conserved proteins ranging in molecular weight
from 20–75 kDa. SR proteins have well-characterized roles in pre-
mRNA splicing including exon definition and assembly of the
mature spliceosome [4,5]. A subset of the SR protein family also
function outside pre-mRNA splicing [6]. Indeed, we recently
established a role of the shuttling SR protein SF2/ASF in mRNA
translation [7,8]. SF2/ASF enhances translation initiation by
promoting phosphorylation of the translational repressor protein
4E-BP1 by the mammalian target of rapamycin (mTOR) [9].
Further roles for SRp20 and 9G8 in internal ribosome entry site
(IRES)-mediated translation and intronlessmRNAexport have been
documented [10,11]. These observations suggest the hypothesis that
shuttling SR proteins may couple nuclear and cytoplasmic steps of
pre-mRNA processing. Elucidating endogenous mRNA targets that
are regulated by SF2/ASF in both the nucleus and cytoplasm is
critical to testing the validity of this hypothesis.
The cross-linking immunoprecipitation (CLIP) method is a
powerful method for elucidating the target specificity of RNA
binding proteins in vivo [12]. In this protocol, living cells are
exposed to UV irradiation to induce covalent cross-links between
RNA binding proteins and their in situ RNA targets. Prior to
immunoprecipitation of a specific RNA binding protein lysates are
treated with RNase in order to generate 40–60 nt cross-linked
RNA tags. Co-purifying RNA tags are then cloned and sequenced
PLoS ONE | www.plosone.org 1 October 2008 | Volume 3 | Issue 10 | e3369revealing genomic locus of the RNA as well as the position of the
RNA-protein interaction within the RNA molecule. CLIP analysis
of the neural specific splicing factor Nova identified a post-
transcriptional regulatory network related to synaptic function.
Mechanistic studies determined the relationship between positions
of Nova binding sites and effects on splice site selection [13,14].
These data were used to build an RNA map capable of predicting
Nova-dependent splice site selection [15]. Here, we use CLIP to
identify RNA targets for the shuttling SR protein, SF2/ASF, in
order to test the hypothesis that this SR family protein member
regulates nuclear and cytoplasmic expression of specific mRNAs in
living cells. This sampling of nuclear, cytoplasmic and polyribo-
some-associated mRNA targets suggests that SF2/ASF may
remain associated with a subset of specific transcripts as they are
trafficked from the nucleus to the cytoplasm. Furthermore we
provide evidence that SF2/ASF couples alternative splicing with
enhanced translation for several endogenous mRNAs. These data
provide insights to the targets and roles of an essential shuttling
RNA binding protein in coupling nuclear and cytoplasmic steps of
post-transcriptional gene expression.
Results
Cross-linking immunoprecipitation of SF2/ASF
Previously, we have shown that SF2/ASF binds directly to
cytoplasmic mRNA in vivo and enhances the translation of reporter
mRNAs both in vitro and in vivo [8], suggesting that SF2/ASF may
regulate the nuclear and cytoplasmic fate of specific endogenous
mRNAs. Despite nearly two decades of study, few endogenous
targets of SR proteins have been identified. In order to determine
if SF2/ASF can regulate nuclear and cytoplasmic processing of
endogenous mRNAs we used the CLIP protocol to identify
binding sites for SF2/ASF in mRNAs from different subcellular
fractions. Nuclear, cytoplasmic and polyribosome-containing sub-
cellular fractions were prepared as previously described [7] from
control cells or those exposed to UV irradiation and cell extracts
were treated with decreasing amounts of RNase A/T1 to partially
degrade cross-linked RNA molecules. SF2/ASF was immunopre-
cipitated from each extract under stringent conditions. Purified
SF2/ASF-RNA complexes were modified on beads by the
addition of a 39 RNA linker and
32P at the 59 end. Complexes
were resolved on 10% Novex Nupage gels (Invitrogen, USA) and
transferred to nitrocellulose. Fig. 1 shows UV-dependent, RNase-
sensitive complexes immunoprecipitated by the anti-SF2/ASF
monoclonal antibody. Note the increased molecular weight of the
complex as RNase concentrations are decreased. The heteroge-
neous migration of these complexes is due to increasing length of
captured RNA fragments. Complexes between 37 and 42 kDa
were purified from nitrocellulose membranes. RNA was extracted,
ligated to a 59 RNA linker and amplified by RT-PCR (not shown).
Amplicons were then concatamerized, ligated in pcDNA3.1,
cloned and sequenced.
Mapping of SF2/ASF mRNA targets
We obtained sequences from more than 3,500 amplicons
corresponding to putative SF2/ASF RNA targets. We used BLAT
to align sequences to the human genome allowing for two mis-
matches or gaps within the alignment [16]. For this analysis we
focused on RNA fragments corresponding to protein coding genes,
any other sites were ignored. 1,237 amplicons could be mapped to
a total of 326 positions in 180 protein coding genes; 43% of the
binding sites were represented by multiple sequences. A majority
of binding sites (68%) fell within exonic sequences (Fig. 2A). We
also detected binding sites for SF2/ASF within intronic sequences.
However, as shown below, we were unable to detect a consensus
motif within the pool of intronic binding sites, therefore we focused
the remaining analysis on the exonic pool of sequences. We
compared the binding specificity of SF2/ASF RNA targets
identified in different sub-cellular compartments in order to
determine if any RNA transcripts were in common. We found that
72 exonic binding sites are engaged by SF2/ASF in both the
nucleus and the cytoplasm or polysome fraction. Interestingly, 15
binding sites in 12 different genes are engaged by SF2/ASF in all
three compartments (Fig. 2B). These data provide strong evidence
that SF2/ASF associates with a subset of messenger RNAs in the
nucleus and that the same cis-acting element is recognized in the
cytoplasm. We hypothesize that SF2/ASF remains bound to the
mRNA as the mRNA is trafficked from the nucleus to the
cytoplasm [7].
Figure 1. Cross-linking immunoprecipitation of SF2/ASF from different HEK293T cellular fractions. SF2/ASF-RNA complexes, indicated
by the bracket, were visualized by autoradiography. Positions of molecular weight standards are given at the left of each panel and exposure of cells
to ultra violet radiation (UV) is indicated by + or 2.
doi:10.1371/journal.pone.0003369.g001
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The in vitro RNA binding specificity of many SR proteins
including SF2/ASF, have been well-characterized using approaches
such as selected evolution of ligands by exponential enrichment
(SELEX) [17]. Different consensus sites for SF2/ASF have been
obtained using different SELEX strategies [18,19]. We used the
motif finding algorithm MEME, to search exonic or intronic RNA
fragmentsforoverrepresented sequences[20,21].Fig.3Ashowsthat
a purine-rich consensus motif is present within exonic sequences
targeted by SF2/ASF with a highly significant expectation value (e
value) of 3.8610
24. No other statistically significant motifs were
identified within the exonic sequences. By contrast MEME was
unable to detect an enriched sequence motif within the intronic pool
of binding sites identified by CLIP. These data suggest that intronic
binding sites may prove to be a nonspecific contaminant. To test the
validityoftheconsensusmodel,we askediftheconsensussequenceis
enriched in exonic or intronic sequences across the genome using
composite exons [18]. We then used the position weight matrix
calculated from the consensus motif to determine the number of
binding sites at each position across all intron/exon/intron
composite sequences. Fig. 3B demonstrates that the consensus motif
for SF2/ASF is highly enriched at the edges of exons relative to
intronic sequences or the interior of exon sequences. These data
support the hypothesis that SF2/ASF plays a role in the
establishment of exon identity.
Annotation of alternatively spliced pre-mRNA targets of
SF2/ASF
SR proteins have well characterized roles in both constitutive
and alternative pre-mRNA splicing. Resolving these dual functions
of SR proteins solely by the use of heterologous substrates and
mini-gene reporters has proven difficult. In order to determine if
the endogenous binding sites for SF2/ASF may reveal any clues to
the roles of SR proteins in alternative splicing we manually curated
annotated ENSEMBL transcripts targeted by SF2/ASF for
examples of alternative splicing using two distinct databases:
AceView and FAST-DB [22,23]. Of the 234 exonic binding sites
identified by CLIP, only 72 were subject to some form of
alternative processing (Table 1–4 for details on binding sites
associated with specific types of alternative splicing). We also
identified 9 binding sites within constitutive exons located
downstream and adjacent to alternative cassette exons (See
Table 5). This type of arrangement suggests that SF2/ASF may
promote skipping of the upstream cassette exon, as recently
demonstrated for alternative splicing of the receptor tyrosine
kinase RON during breast cancer metastasis [24]. Within this list
of alternative exons targeted by SF2/ASF there is a modest
enrichment for genes encoding RNA binding proteins (SFRS1,
PABPC1, hnRNPDL, hnRNPAB, SERBP1, RPL5, SON, RPL0,
Figure 2. Distribution of SF2/ASF binding sites in relation to gene structure and sub-cellular localization. A) The ‘‘coding’’ SF2/ASF CLIP
tags from nuclear, cytoplasmic and polysomal sets were analyzed in relation to their relative position within genes. This showed that the majority
map to intronic or to coding exonic sequences and only a small proportion mapped to UTRs. B) Venn diagram of exonic SF2/ASF binding sites from
Nuclear, cytoplasmic and polysomal sub-cellular fractions. The number of unique binding sites identified in each fraction is designated as ‘‘n’’.
doi:10.1371/journal.pone.0003369.g002
Figure 3. Identification of the SF2/ASF consensus binding site
and its frequency distribution in coding exons and flanking
introns. A) The exonic or intronic clip tags were analyzed using MEME to
identify sequence patterns that are over-represented. MEME was unable
to identify a consensus motif within the intronic binding sites. B) This
pattern wasusedtoanalyzecompositesequences madeforall exonswith
more than 100 nucleotides, from protein coding genes. This analysis
shows that the pattern is over-represented within exonic sequences and
in particular within the exon 59 prime and middle of the exons.
doi:10.1371/journal.pone.0003369.g003
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regulation of biological processes such as cell division, proliferation
and apoptosis (CDK4, MAPK3, ACIN1). The ENSA gene is also
of interest as it is bound by SF2/ASF in each sub-cellular
compartment and is a Type 2 diabetes candidate gene. ENSA is an
endogenous ligand for the sulfonylurea receptor which plays an
important role in insulin release from pancreatic beta cells [25,26].
Several of the alternative splicing events involving exons targeted
by SF2/ASF lead to premature termination codons and
potentially NMD (SFRS1, CDK4, MAPK3, for example) however
the majority of alternative events alter the primary structure of the
encoded polypeptide (not shown). All of these splicing events can
be visualized using the Friendly Alternative Splicing and
Transcript Diversity database (http://www.fast-db.com; [22]).
Regulation of endogenous nuclear and cytoplasmic
mRNA processing by SF2/ASF
A majority of RNA fragments that co-purified with SF2/ASF
contain a purine-rich consensus motif, reminiscent of previous
SELEX binding sites [19]. Interestingly, a subset of mRNA targets
was bound by SF2/ASF in both the nucleus and the cytoplasm.
Three of these targets, ENSA (endosulfine a), PABPC1 (poly A
binding protein 1) and NETO2 (neuropillin-like tolloid receptor 2)
contained binding sites for SF2/ASF within or flanking alternative
cassette exons, whereas the SFRS1 (pre-mRNA encoding SF2/
ASF) contains a binding site adjacent to a retained intron. We then
asked whether SF2/ASF modulates the alternative splicing of
these pre-mRNAs in the nucleus and enhance their translation in
the cytoplasm. We manipulated the levels of SF2/ASF in
HEK293T cells by transfecting cells with siRNA targeting
endogenous SF2/ASF, scrambled control siRNA or plasmid to
increase levels of SF2/ASF by transient ectopic expression and
assayed alternative splicing of endogenous ENSA, SF2/ASF, PABP
and NETO2. Fig. 4A shows a Western blot from control cells (lanes
1,2, and 4, respectively) or cells depleted or over expressing SF2/
ASF (lanes 3 and 5, respectively). In the context of the ENSA pre-
mRNA, the observed binding site is located within an alternative
cassette exon. As expected ectopic expression of SF2/ASF increases
inclusion of the alternative exon, relative to the cells depleted for
SF2/ASF (Fig. 4B). Binding sites for SF2/ASF within the PABP and
Neto2 pre-mRNAs are in exons proximal to alternative cassette
exons. We found that ectopic expression of SF2/ASF causes
increased skipping of the alternative cassette exon in both cases
(Fig. 4B). Finally, the observed binding site for SF2/ASF within its’
own pre-mRNA (transcribed from the SFRS1 gene) is located near
an ultra-conserved element adjacent to a retained intron within the
39UTR [27,28]. Thisintron isbelieved toattenuate expression ofthe
SFRS1genethroughregulatedunproductivesplicingandtranslation
(RUST) mechanism [27]. We observe that ectopic expression of
SF2/ASF increase splicing of this intron and provides supporting
evidence for the RUST hypothesis (Fig. 4B).
The splicing of each of these endogenous pre-mRNA targets is
effected by increasing the intracellular concentrations of SF2/ASF.
It is known that SF2/ASF can remain associated with mRNA
following the splicing reaction and that SF2/ASF can enhance the
translation of reporter mRNAs [7,8]. The CLIP method revealed
that a subset of SF2/ASF mRNA targets, including PABP,
NETO2, ENSA and SFRS1, were bound by SF2/ASF in the
Table 1. Annotation of alternative cassette exons bound by SF2/ASF.
Partial list of alternative cassette exons bound by SF2/ASF
Gene ID
Exon
Position Gene Description Localization Gene Family Function
ACIN1 12 apoptotic chromatin condensation
inducer 1
Nucleus enzyme apoptotic chromosome
condensation
BECN1 11 beclin 1 (coiled-coil, myosin-like BCL2
interacting protein)
Nucleus; Polysome other anti-apoptosis;cellular defense
response
CALM2 4 calmodulin 2 (phosphorylase kinase,
delta)
Cytoplasm other Calcium Binding;G-protein coupled
receptor protein signaling pathway
DHX15 5 DEAH (Asp-Glu-Ala-His) box polypeptide
15
Cytoplasm enzyme mRNA processing
ERCC6 2 excision repair cross-complementing
rodent repair deficiency, complementation
group 6
Cytoplasm transcription regulator transcription-coupled nucleotide-
excision repair
MAPK3 6 mitogen-activated protein kinase 3 Cytoplasm kinase intracellular signaling cascade
NUP43 4 nucleoporin 43kDa Nucleus; Cytoplasm; Polysome transporter nuclear envelope
PIP5K2A 7 phosphatidylinositol-5-phosphate 4-kinase,
type II, alpha
Nucleus kinase glycerophospholipid metabolic
process
SON 3 SON DNA binding protein Nucleus other anti-apoptosis
TCF12 9 transcription factor 12 (HTF4, helix-loop-
helix transcription factors 4)
Cytoplasm transcription regulator regulation of transcription from RNA
polymerase II promoter
WDR42A 11 WD repeat domain 42A Nucleus; Cytoplasm other Unknown
Y13871 1 hypothetical protein LOC202181 Nucleus; Cytoplasm; Polysome other Unknown
ZHX1 3 zinc fingers and homeoboxes 1 Nucleus transcription regulator negative regulation of transcription,
DNA-dependent
Exons were annotated manually according to AceView and FAST-DB databases. Column Headers: Gene ID, official gene symbol; Exon position, number of exon within
the primary transcript; Gene Description; Localization, the sub-cellular fraction used for CLIP experiment; Gene Family; Function, the primary encoded function of gene.
This table is a partial list of cassette exons bound by SF2/ASF. The complete list can be found in Table S1.
doi:10.1371/journal.pone.0003369.t001
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ASF may also enhance the translation of these particular mRNA
targets. To test this hypothesis we asked whether a specific mRNA
target of SF2/ASF exhibited increased association with polyribo-
somes, the actively translating pool of ribosomes, when SF2/ASF
is overexpressed. Cytoplasmic extracts were prepared from
HEK293T cells transfected with empty expression vector or
epitope tagged SF2/ASF (Fig. 5A). Cytoplasmic extracts were
resolved across 10–45% sucrose gradients. Following fraction-
ation, total RNA was extracted from every other fraction and
cDNA was synthesized using oligo dT primer. Upon ectopic
expression of SF2/ASF all four endogenous mRNA targets
showed increased association with polyribosomes (Fig. 5A, lanes
5–8). By contrast, levels of GAPDH remain constant across the
gradient when SF2/ASF is overexpressed. We also examined the
distribution of several other endogenous targets, but found no
difference when SF2/ASF is over expressed, suggesting that this
effect is specific for a subset of transcripts rather than a global
phenomenon (data not shown). Additionally, there are no obvious
differences between the distributions of total RNA across the
gradient. These data are in good agreement with our previous
findings that SF2/ASF can enhance the polysome association and
translation of luciferase reporter mRNAs both in vitro and in vivo
[7–9]. Finally these data provide clear evidence that SF2/ASF can
drive enhaced polysome association of endogenous mRNAs in vivo.
Discussion
SF2/ASF is a nucleo-cytoplasmic shuttling RNA binding
protein with clearly defined activities in spliceosome assembly.
Our previous work established a role for SF2/ASF in mRNA
translation [7,8]. These findings suggested that SF2/ASF may co-
ordinate the nuclear and cytoplasmic steps of post-transcriptional
gene expression for a subset of pre-mRNAs. This hypothesis is
further supported by the observation that extrinsic signals leading
to activation of the AKT protein kinase enhance the alternative
splicing and translation of reporter RNAs containing a consensus
SF2/ASF binding site [29]. We used the CLIP protocol to extend
our findings to endogenous cellular mRNAs. CLIP allowed us to
sample direct mRNA targets of SF2/ASF under conditions that
preserve the in situ specificity of protein-RNA interactions. By
coupling CLIP with sub-cellular fractionation we were able to
identify mRNAs associated with SF2/ASF in the nucleus,
cytoplasm and in the actively translating pool of ribosomes
Table 2. Annotated as described in Table 1.
SF2/ASF target exons containing alternative 39 splice sites
Gene ID
Exon
Position Gene Description Localization Gene Family Function
PSAP 7 prosaposin Nucleus other glycosphingolipid metabolic process;
lipid transport
HN1 3 hematological and neurological expressed 1 Nucleus other Not Determined
IGF1R 21 insulin-like growth factor 1 receptor Nucleus transmembrane receptor insulin receptor signaling pathway
PRELID1 5 PRELI domain containing 1 Nucleus other multicellular organismal development
CALM2 3 calmodulin 2 (phosphorylase kinase, delta) Cytoplasm other Calcium Binding; G-protein coupled
receptor protein signaling pathway
AHCY 10 S-adenosylhomocysteine hydrolase Cytoplasm enzyme one-carbon compound metabolic process
ZFP91 11 zinc finger protein 91 homolog (mouse) Cytoplasm transcription regulator
UBE3B 28 ubiquitin protein ligase E3B Cytoplasm enzyme Protein degredation
RPL10A 6 ribosomal protein L10a Cytoplasm other Ribosome Component
GK 17 glycerol kinase Cytoplasm kinase
RPS10 3 ribosomal protein S10 Nucleus; Cytoplasm other Ribosome Component
MGST3 2 microsomal glutathione S-transferase 3 Nucleus; Cytoplasm enzyme lipid metabolic process; signal
transduction
RPL19 6 ribosomal protein L19 Nucleus; Cytoplasm other Ribosome Component
NAGPA 5 N-acetylglucosamine-1-phosphodiester
alpha-N-acetylglucos-aminidase
Nucleus; Cytoplasm enzyme carbohydrate metabolic process;
lysosome organization and biogenesis
B2M 2 beta-2-microglobulin Nucleus; Cytoplasm transmembrane receptor immune response
ETNK1 2 ethanolamine kinase 1 Cytoplasm; Polysome kinase Phosphatidylethanol-amine biosynthetic
process
EEF1A1 3,6 eukaryotic translation elongation factor 1
alpha 1
Nucleus; Cytoplasm;
Polysome
translation translational elongation
FLJ00313 7 Not Determined Nucleus Unknown Unknown
NR2C1 12 nuclear receptor subfamily 2, group C,
member 1
Nucleus transcription regulator Unknown
PWP1 13 PWP1 homolog (S. cerevisiae) Nucleus other Unknown
CENPO 5 centromere protein O Nucleus other role in cell growth and/or transcription
TCF12 9 transcription factor 12 Cytoplasm transcription regulator Regulation of transcription by RNA
Polymerase II
doi:10.1371/journal.pone.0003369.t002
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splicing and translation may be coordinated by SF2/ASF.
Collectively, our data do not support the view that SF2/ASF
plays a general role in mRNA translation, but suggests that the
biological importance of this aspect of SF2/ASF function may be
at transcript and cell types-specific events. Our recent findings that
mTOR is critical to translational control by SF2/ASF suggest that
SF2/ASF may connect cellular signal transduction pathways with
post-transcriptional control of specific target mRNAs [9].
Using the CLIP approach we were able to not only identify
potential RNA targets for SF2/ASF but also define a consensus
binding motif present in exonic binding sites (Fig. 3). This purine-
rich motif closely resembles the well-characterized exonic splicing
enhancers (ESE) present in the fibronectin EDA alternative
cassette exon as well as exon 5 of the cardiac troponin T (cTNT)
gene [30,31]. The binding specificity of SR proteins has also been
extensively studied using SELEX strategies. Our data are in good
agreement from results obtained using only the RRM domains of
Table 3. Annotated as described in Table 1.
SF2/ASF target exons containing alternative 59 splice sites
Gene ID
Exon
Position Gene Description Localization Gene Family Function
NAGPA 5 N-acetylglucosamine-1-phosphodiester
alpha-N-acetylglucosaminidase
Nucleus; Cytoplasm enzyme carbohydrate metabolic process; lysosome
organization and biogenesis
SERBP1 6 SERPINE1 mRNA binding protein 1 Nucleus other mRNA processing
CDK4 2 cyclin-dependent kinase 4 Nucleus kinase Cell Cycle Regulation
CDC14A 15 CDC14 cell division cycle 14 homolog
A (S. cerevisiae)
Nucleus phosphatase dual specificity protein tyrosine phosphatase
BCOR 4 BCL6 co-repressor Cytoplasm transcription regulator Transcriptional corepressor
RPL5 1 ribosomal protein L5 Cytoplasm other Ribosome Component
NOL1 16 nucleolar protein 1, 120kDa Polysome other Cell Cycle Regulation; RNA Methyltransferase
PKM2 2 pyruvate kinase, muscle Cytoplasm; Polysome kinase Glycolytic enzyme
ETNK1 2 ethanolamine kinase 1 Cytoplasm; Polysome kinase phosphatidylethanolamine biosynthetic process
MAPK3 6 mitogen-activated protein kinase 3 Cytoplasm kinase intracellular signaling cascade
EEF1A1 2,3,6 eukaryotic translation elongation
factor 1 alpha 1
Nucleus; Cytoplasm;
Polysome
translation translational elongation
doi:10.1371/journal.pone.0003369.t003
Table 4. Annotated as described in Table 1.
SF2/ASF target exons containing a retained intron
Gene ID
Exon
Position Gene Description Localization Gene Family Function
ATP5B 2 ATP synthase, H+ transporting, mitochondrial F1
complex, beta polypeptide
Nucleus; Cytoplasm transporter generation of precursor metabolites
and energy
ATP7B 2 ATPase, Cu++ transporting, beta polypeptide Nucleus transporter cellular copper ion homeostasis
EEF1A1 1 eukaryotic translation elongation factor 1 alpha 1 Nucleus; Cytoplasm;
Polysome
translation regulator translational elongation
GNL3 13 guanine nucleotide binding protein-like 3 (nucleolar) Cytoplasm other Stem Cell Proliferation
NAGPA 5 N-acetylglucosamine-1-phosphodiester alpha-N-
acetylglucosaminidase
Nucleus; Cytoplasm enzyme carbohydrate metabolic process;
lysosome organization and biogenesis
RAN 7 RAN, member RAS oncogene family Nucleus enzyme GTP-binding protein involved in
nucleocytoplasmic transport
RPL12 7 ribosomal protein L12 Nucleus other Ribosome Component
RPL23 3 ribosomal protein L23 Polysome other Ribosome Component
RPLP0 5 ribosomal protein, large, P0 Nucleus other Ribosome Component
SFRS1 4 splicing factor, arginine/serine-rich 1 (splicing factor 2,
alternate splicing factor)
Cytoplasm other mRNA processing
TH1L 15 TH1-like (Drosophila) Cytoplasm other Transcription regulator
TSSC4 4 tumor suppressing subtransferable candidate 4 Nucleus other Unknown
WDR59 12 WD repeat domain 59 Nucleus transporter Not Determined
ZMYM3 7 zinc finger, MYM-type 3 Cytoplasm other multicellular organismal development
doi:10.1371/journal.pone.0003369.t004
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functional SELEX experiments, in which bona fide ESEs within
reporter constructs are replaced by randomized sequence and in
vitro splicing is driven by a single recombinant SR protein in S100
complementation assays, yielded different consensus motifs for
SF2/ASF [18]. The functional SELEX motifs are more
heterogeneous in nature but may represent binding sites for
SF2/ASF that can lead to productive splicing. The differences
between motifs identified by functional SELEX and CLIP may
reflect inherent differences in the experimental conditions. For
example, photo cross-linking of protein-RNA interactions is
believed to be fairly inefficient, but it allows for recovery of
sequences under stringent conditions. It remains possible that
sequences identified by CLIP represent only a subset of possible
binding sites that are both abundant and suitable for cross-linking.
Data presented in Fig. 4B demonstrates that SF2/ASF can
regulate the alternative splicing of a subset of pre-mRNAs
suggesting that the observed binding sites are functionally relevant.
Indeed, 26 out of 44 endogenous pre-mRNAs containing binding
sites for SF2/ASF within or proximal to cassette exons appear to
be functionally relevant when tested by RT-PCR (Fig. 4B and data
not shown). Thus we feel the CLIP method has captured a subset
of biologically relevant SF2/ASF binding sites.
Cataloguing the collection of cis-acting elements directing post-
transcriptional gene regulation on a global scale is only at the
initial stages of investigation. In silico studies have successfully
elucidated cis-acting elements that are enriched or co-evolve with
constitutive and alternative exons. Several recent computational
screens have defined thousands of hexa- or octamers as splicing
regulatory sequences [32–34]. If a combinatorial code governing
splice site selection exists, the solution will likely emerge through
interdisciplinary approaches merging computational methods with
biochemical and functional genomics approaches. Methods such
as SELEX, CLIP and RIP-Chip have the potential to illuminate
the specificity and functions of RNA binding proteins by making
connections between trans-acting RNA binding proteins and the
biological processes they regulate [13,35–37]. CLIP also provides
the added value of determining potential mechanisms of RNA
binding protein action by revealing the positional context of cis-
acting RNA elements within a transcript [13]. RNA binding
protein target specificity can also be evaluated using platforms to
profile alternative splicing such as exon tiling arrays, spliced
junction array platforms and RNA-Seq [38–40]. Discrimination of
direct versus indirect effects is a limitation of these experiments
however this may be overcome by applying computational models
of consensus binding sites generated by CLIP or SELEX to classify
global changes in alternative splicing [39,41]. Our initial CLIP
experiment with SF2/ASF revealed just a small snap shot of
putative RNA targets. One clear limitation of this study is the
inefficiency of the Sanger sequencing. Merging CLIP with high
throughput genome wide sequencing platforms such as Solexa and
454 (Illumina, USA and Roche Diagnostics, USA, respectively),
will vastly expand our ability to define the RNA binding
specificity. These data will allow for a high resolution map of
SF2/ASF binding sites that not only illuminate mechanisms of
action in pre-mRNA splicing but also reveal connections to
important biological processes such as genome stability, cellular
transformation and non-coding RNA processing.
Materials and Methods
Cell culture and transient transfection
For CLIP analysis of SF2/ASF, HEK293T cells were grown to
75–80% confluence at 37uC, 5% CO2. HEK293T cells were
cultured in DMEM containing 10% Fetal Calf Serum and
antibiotics. Transient transfection of HEK293T cells with plasmid
DNA was performed using Lipofectamine 2000 (Invitrogen)
following the manufacturers instructions. Transient transfection of
siRNA duplexes and plasmid DNA were performed using Duo-fect
transfection reagent (Dharmacon) following the manufacturers
specifications. Cells were harvested 48 hours following transfection.
siRNA transfection efficiency was monitored using siGLO green
siRNA duplexes (Dharmacon) and was found to be 80–95% efficient.
Plasmids and siRNA
T7 Epitope tagged SF2/ASF was expressed from the pCGT7
vector and has been described previously [42]. siRNA Smartpools
targeting the endogenous SF2/ASF transcript, or scrambled
nontargeting siRNA duplexes were purchased from Dharmacon.
Cross-linking Immunoprecipitation of SF2/ASF from
HEK293T cells
CLIP analysis of SF2/ASF was performed as described by Ule
et al.[32] with the following modifications relating to extract
Table 5. Annotated as described in Table 1.
SF2/ASF target exons located adjacent to alternative cassette exons
Gene ID
Exon
Position Gene Description Localization Gene Family Function
NETO2 9 neuropilin (NRP) and tolloid (TLL)-like 2 Cytoplasm Transmembrane Protein development; neuronal function
PRKRA 4 protein kinase, interferon-inducible double stranded
RNA dependent activator
Cytoplasm Kinase Pro-apoptosis
RPS24 6 ribosomal protein S24 Cytoplasm Ribosome Component Translation factor
PABPC1 12 poly(A) binding protein, cytoplasmic 1 Nucleus; Polysome Other translation regulator
BRD2 13 bromodomain containing 2 Nucleus kinase generation of spermatozoa
YWHAH 2 tyrosine 3-monooxygenase/tryptophan 5-
monooxygenase activation protein, eta polypeptide
Nucleus; Cytoplasm Other transcription regulator
HNRPDL 9 heterogeneous nuclear ribonucleoprotein D-like Nucleus Other mRNA processing
HNRPAB 8 heterogeneous nuclear ribonucleoprotein A/B Nucleus Other mRNA processing
MPZL1 6 myelin protein zero-like 1 Nucleus; Cytoplasm Transmembrane Protein Receptor
doi:10.1371/journal.pone.0003369.t005
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extracts were prepared from UV-treated or control cells as
previously described [7]. The soluble extract was treated with
30 U RQ DNase 1 for 20 min at 37uC. The reactions were
terminated by the addition of 20 mM EDTA. Subsequently,
ribosomal subunits were cleared by centrifugation of the extract at
100,0006 g using an Optima Max ultracentrifuge (Beckman
Coulter, USA) in a TLA120.2 rotor for 20 min. Cleared extracts
were then treated with a dilute cocktail of RNase A/T1 (Ambion,
USA) at a final dilution range of 1:1000–1:10,000 for 20 min at
37uC. 200 U RNaseOut (Invitrogen, USA) was then added to the
extract. Proteins were then partially denatured by addition of an
equal volume of buffer A (26 PBS, 0.2% SDS, 1% NP-40). An
aliquot of each UV-treated extract was used to prepare input RNA
fragments. The remainder of the extract was used for immuno-
precipitation with anti-SFRS1 monoclonal antibody.
Characterization of the CLIP tags
All Human exon and gene information was downloaded from
Ensembl, using the BioMart tool. The sequence data was
downloaded using Perl scripts to access the ensembl database
through the Ensembl Core Perl API. The CLIPS sequences were
mapped against unspliced gene, cDNA and coding sequences using
Mega BLAST (Zhang et al. 2000). The unambiguous mapping of
the CLIP tags allowed us to match the CLIPs to Ensembl gene ids.
The characterization of type of splicing event that occurs on the
alternatively spliced exons that were found to be bound by SF2/ASF
was performed according to Ensembl exon information.
Identification of the SF2/ASF binding site
The distinct CLIP tags that match exons were used on the
MEME (Bailey et al., 2006) web server (http://meme.sdsc.edu/
meme/meme.html) to identify patterns that are probabilistically
significant. The intronic set of CLIP tags was used in the same way
but did not result in any meaningful pattern.
The genome wide distribution of the SF2/ASF binding
site pattern
To identify the genome-wide distribution of SF2/ASF binding
sites around exon splice sites, for each exon from a protein coding
gene (greater than 100 bp), we generated a composite sequence
made of the 75 bp upstream of the 39 splice site, the 59 exonic
25 bp, the 50 bp from the middle of the exon, the 25 bp 39 exonic
and 75 bp downstream of the 59 splice site. There were in total
174,440 exons that satisfied this criteria. These were then analyzed
using the binding sites in CLIP tags that were identified by
MEME.
Parsing of Data
All parsing of data was performed using multiple Perl scripts.
in vivo splicing assay
HEK293T cells were transfected as described above. Cells were
harvested 48 hours post-transfection. One aliquot was used for
western blot analysis the other was used to prepare total RNA
from the cytosolic fraction. RNA was extracted using TRI
Reagent LS (Sigma) following the manufacturers instructions.
cDNA was synthesized using oligo dT primer and Superscript RT
III (Invitrogen). 50 ng of cDNA was used as a template for RT-
PCR analysis. Primers were 59 end labelled with
32PcATP and T4
PNK (NEW England Biolabs). Primers are available upon request.
PCR was performed using the following conditions: 3 min at
94uC; 30 cycles of 94uC 30 sec, 59uC 30 sec, 72uC 60 sec; 72uC
5 min. Following PCR, the reactions were ethanol precipitated
and resolved upon 10% polyacrylamide/7M urea gels. RT-PCR
reactions were visualized by autoradiography or phosphorimager.
Figure 4. Alternative splicing of endogenous RNA transcripts
targeted by SF2/ASF. A) Western blot analysis of HEK293T cells co-
transfected with siRNA duplexes and expression plasmids. The upper
panel is probed with anti-SF2/ASF monoclonal antibody, the lower panel
is probed with anti-GAPDH monoclonal antibody. Lane 1, non transfected
control (NTC); Lane2,Mock (no siRNA or plasmid); Lane3, siRNA targeting
SF2/ASF and empty vector (pCGT7); Lane 4, scrambled siRNA and empty
vector; Lane 5, scrambled siRNA and T7-tagged SF2/ASF expression
plasmid (pCGT7 SF2). Total RNA was purified for RT-PCR analysis from
samples corresponding to lanes 3 and 5. B) RT-PCR analysis of alternative
splicing. Radiolabeled products were visualized by phosphorimaging.
Schematic diagrams show exon-intron structure of target genes and
patterns of alternative splicing. Thin rectangles indicate untranslated
regions, thick rectangles indicate coding regions, thick lines indicate
introns and thin lines indicate the alternative splicing event. Exons
identifiedbyCLIPareyellow. Thegrey regioninthe SFRS1 39UTRindicates
a retained intron. Arrowheads to the left of each panel indicate the
included (gray arrowhead) and skipped (black arrowhead) alternative
mRNA isoform. Lane 1 and 2 contain RNA purified from SF2/ASF
overexpressing and depleted cells, for example see panel A, lanes 5 and 3,
respectively. The sub-cellular fraction corresponding to the initial CLIP
experiment is indicated below each gene symbol.
doi:10.1371/journal.pone.0003369.g004
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Polyribosome profiles were obtained from HEK293T cells as
previously described [7,8]. Total RNA was extracted from each
fraction using TRI Reagent LS. Every other fraction was analyzed
by RT-PCR. Purification of polyribosome for CLIP analysis of SF2/
ASF was accomplished by pelleting polyribosomes through 10–25%
sucrose gradients as previously described [8]. Polysome pellets were
washed gently with cold PBS, then resuspended in cold 0.56buffer
A (see above). The polysomes were then treated with RQ DNase,
and RNase as described in the CLIP protocol [12].
Supporting Information
A supplementary excel spread sheet accompanies this manuscript
(Table S1). It contains complete annotation of the CLIP data.
Supporting Information
Table S1 A complete list of binding site annotation using the
Ensembl, UCSC Known Gene and Rfam databases. The Excel file
can be filtered in order to find binding sites identified by CLIP using
nuclear, cytoplasmic or polysomal extracts. Headers for the table are
as follows: Chromosome: Defines the specific chromosome from the
human genome to which the seq-block mapped. Strand: CLIP
preserves the orientation of the captured RNA marker, so that it is
possible to determine the strandedness of the locus. Id: Generic
description given to each binding site during our annotation work
flow. Region start/end: The precise chromosomal coordinates
defining the unique or overlapping sequence blocks. Regions are
define by at least 2 partially overlapping binding sites mapping to the
locus. # of fragments in the Cytoplasm/Nucleus/Polysome indicates
if the binding site was identified in each compartment. The number
specifies whether a sequence block was absent, present in a single
assay or multiple assays. # of sample targets is useful for finding
binding sites that are in 1, 2 or all three cellular fractions. Gene
Annotation: This column describes the relationship of the seq block to
annotated protein coding genes based on the UCSC Known Gene
D a t a b a s e .E x o nS t y l e :T h i sc o l u m nd e s c r i b e st h er e l a t i o n s h i po ft h e
seq block toannotatedpartsofprotein coding genes(exon, intronetc).
The strategy is presented in Supplementary Figure 2. USCS Known
Gene database ID: This column refers to the name of a specific gene
cluster by the UCSC Known Gene database. Gene Symbol: This
column contains information pertaining to the approved HUGO
Gene Nomenclature Committee symbol for each protein coding
gene. Exon Position: This column describes the position of the exon
within the protein coding gene. First/Last exon columns: Designation
of ‘‘1’’ in either column indicates 59 or 39 terminal exon. ‘‘1’’ in both
columns denotes that the sequence block is in a single exon gene.
Upstream/Downstream Exon Position: These columns are useful for
determining the position of introns within a protein coding gene.
ncRNA Annotation: Describes the relationship of a sequence block to
annotated non coding RNA (ncRNA). Annotation is based on the
Rfam database. ncRNA Name: This column describes the gene
symbol for each ncRNA containing a sequence block. UTR type:
Describes the relationship between sequence blocks and untranslated
regions of protein coding genes. Splicing Event: Gives alternative
splicing annotation for exonic binding sites based upon AceVIEW,
ALT Events and Fast-db, databases.
Found at: doi:10.1371/journal.pone.0003369.s001 (0.13 MBXLS)
Figure 5. Polyribosome association of endogenous SF2/ASF
mRNA targets. A) Western blot analysis of cytoplasmic extracts
prepared from cells transfected with pCGT7 of pCGT7 SF2/ASF (lanes 1
and 2, respectively). Blots were probed with anti-SF2/ASF and anti-
GAPDH (left and right panel, respectively). B) Polyribosome association
of endogenous mRNAs. Cytoplasmic extracts from control or pCGT7
SF2/ASF cells were resolved by sucrose gradient fractionation. The
upper panel shows the absorbance of rRNA across the gradient, the
positions of ribosomal subunits and complexes are indicated. Lower
panels: RT-PCR analysis of RNA targets. Products were resolved by
agarose gel electrophoresis. The sub-cellular fraction corresponding to
the initial CLIP experiment is indicated below each gene symbol.
doi:10.1371/journal.pone.0003369.g005
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